Aoxing Pharmaceutical Company, Inc. (AOXG)

AOXG Income Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Selling, General & Admin	0.01	0.01	0	0	0	0
Operating Expenses	0.01	0.01	0	0	0	0
Operating Income	-0.01	-0.01	0	0	0	0
Other Expense / Income	0	0	-	-	-	-
Pretax Income	-0.01	-0.01	0	0	0	0
Net Income	-0.01	-0.01	0	0	0	0
Shares Outstanding (Basic)	341	341	-	-	-	-
Shares Outstanding (Diluted)	341	341	-	-	-	-
Shares Change	347.73%	-	-	-	-	-
Free Cash Flow	-2.82	-0.01	0	0	0	0
Free Cash Flow Per Share	-0.01	-0.00	-	-	-	-
EBITDA	-0.01	-0.01	0	0	0	0
Depreciation & Amortization	0.74	0	0	0	0	0
EBIT	-0.75	-	-	-	-	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.